A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

For people living with Type 1 Diabetes (T1D), keeping blood sugar levels in check is a constant challenge. A new clinical trial at UVA is aiming to simplify diabetes management by testing an ...

This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

The US FDA warns users of smartphone-linked diabetes devices like CGMs and insulin pumps of potential health risks due to ...

Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...